XTL Biopharmaceuticals Ltd. - ADR (XTLB)
Market Closed
16 Jun, 20:00
$
2. 38
+0.08
+3.4783%
After Hours
$
+0.09 +3.7815% 2. 47
5.04M Market Cap
- P/E Ratio
- Div Yield
8,320 Volume
0 Eps
$ 2.3
Previous Close Want to track XTLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XTL Biopharmaceuticals Ltd. - ADR (XTLB) Statistics
Valuation metrics
Market Cap 5.04M
Enterprise value 5.28M
Trailing P/E (ttm) -3.81
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 12.21
Price/Book (mrq) 0.72
Enterprise Value/Revenue 11.7
Enterprise Value/EBITDA -5.67
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.56K
Average volume (90 days) 2.33M
Price summary
52-Week low 2.01
52-Week high 10.28
Beta -
50-Day moving average 2.83
200-Day moving average 3.02
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 25 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.28%
Operating margin -4.82%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 0.61%
Book value per share (mrq) 0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
